Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Mesotheliomas Pleural Clinical Trials

8 recruiting trials for Mesotheliomas Pleural. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
8
Total Trials
8
Recruiting Now
1
Phase 3 Trials
8
Sponsors

Recruiting Trials

RECRUITINGPhase 1NCT03760575

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

The study is a single-arm phase I trial to evaluate the safety, feasibility, and preliminary efficacy of the addition of pembrolizumab and image-guided resection to surgical...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 201 location
RECRUITINGPhase 3NCT04996017

Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)

This is a multicentric double-blind, placebo controlled, phase III trial. In this study, patients who underwent to a surgical resection of pleural mesothelioma and are without...

Sponsor: Gruppo Oncologico Italiano di Ricerca ClinicaEnrolling: 16219 locations
RECRUITINGNCT06451536

Ga-68 FAPI PET Before Immunotherapy

It is aimed to evaluate FAP expression and its success in predicting treatment response before immunotherapy used in the treatment of malignant mesothelioma with Ga68 FAPI PET/CT...

Sponsor: Ankara UniversityEnrolling: 301 location
RECRUITINGPhase 1NCT05304208

dENdritic Cell Therapy Combined With SURgEry in Mesothelioma

The ENSURE trial is an open label, single center, phase 1, feasibility study. Sixteen adult patients diagnosed with resectable epithelioid malignant pleural mesothelioma (MPM)...

Sponsor: Erasmus Medical CenterEnrolling: 161 location
RECRUITINGNCT06581549

Immune Microenvironment and Gene Expression Profiling in Mesothelioma

Pleural and peritoneal mesotheliomas (PPM) are rare cancers mostly related to asbestos-exposure, which are characterized by a complex histopathological diagnosis and staging, few...

Sponsor: Istituto Oncologico Veneto IRCCSEnrolling: 22010 locations
RECRUITINGPhase 2NCT06477419

A Study of Sacituzumab Govitecan in People With Mesothelioma

Participants will receive sacituzumab govitecan until their disease gets worse (progresses), they have severe side effects and cannot continue study treatment, or the participants...

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 337 locations
RECRUITINGPhase 2NCT04400539

The IMmunotherapy Pleural 5-ALA PDT

Pilot study of the feasibility of an innovative multimodal treatment combining intrapleural photodynamic therapy with videothoracoscopy followed by adjuvant immunotherapy with...

Sponsor: University Hospital, LilleEnrolling: 201 location
RECRUITINGNCT07126509

Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma

Purpose of the study: The main purpose of this research study is to see if a surgery procedure (limited partial pleurectomy and decortication) helps symptoms in people who have...

Sponsor: University of ChicagoEnrolling: 301 location